Cargando…

Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia

Detalles Bibliográficos
Autor principal:	Banerjee, Indrajit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Nepal Epidemiological Association 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204065/ https://www.ncbi.nlm.nih.gov/pubmed/30867974 http://dx.doi.org/10.3126/nje.v8i1.21139

Ejemplares similares

Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013)

Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)

People with insomnia: experiences with sedative hypnotics and risk perception
por: Cheung, Janet M. Y., et al.
Publicado: (2015)

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman, Jessica L, et al.
Publicado: (2016)

Bromide as a Sedative and Hypnotic
Publicado: (1881)

Pharmacists' interventions to reduce sedative/hypnotic use for insomnia in hospitalized patients
por: Badr, Aisha F., et al.
Publicado: (2018)

Sedative and hypnotic effects of compound Anshen essential oil inhalation for insomnia
por: Zhong, Yu, et al.
Publicado: (2019)

The Use and Misuse of Sedatives and Hypnotic Drugs
por: Hemphill, R. E.
Publicado: (1957)

Sedative and hypnotic effects of Iranian traditional medicinal herbs used for treatment of insomnia
por: Andalib, Sasan, et al.
Publicado: (2011)

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
por: Roch, Catherine, et al.
Publicado: (2021)

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023)

Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis
por: Rocha, Rebeka Bustamante, et al.
Publicado: (2023)

Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
por: Kishi, Taro, et al.
Publicado: (2021)

Orexin, orexin receptor antagonists and central cardiovascular control
por: Carrive, Pascal
Publicado: (2013)

Sleep, Insomnia and Hypnotics
Publicado: (1892)

The clinical efficacy of orexin antagonists for primary insomnia- A review of the evidence
por: Vasiliu, O.
Publicado: (2023)

Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
por: Xue, Tao, et al.
Publicado: (2023)

Dual orexin receptor antagonists for insomnia in youth with neurodevelopmental disorders: a case series and review
por: Besterman, Aaron D., et al.
Publicado: (2021)

Discovery of Small-Molecule Antagonists of Orexin 1/2 Receptors from Traditional Chinese Medicinal Plants with a Hypnotic Effect
por: He, Jia, et al.
Publicado: (2023)

A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
por: Ziemichód, Wojciech, et al.
Publicado: (2022)

Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018)

Use and Abuse of Hypnotics in Insomnia
Publicado: (1899)

Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users
por: Landry, Ishani, et al.
Publicado: (2022)

Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users
por: Landry, Ishani, et al.
Publicado: (2022)

Sedative-Hypnotic and Receptor Binding Studies of Fermented Marine Organisms
por: Joung, Hye-Young, et al.
Publicado: (2015)

Opportunities and perspectives for developing orexin receptor antagonists
por: Steiner, Michel A., et al.
Publicado: (2014)

Concomitant alcohol and sedative-hypnotic drug use among the elderly in Norway
por: Bye, Elin Kristin, et al.
Publicado: (2017)

Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
por: Okuda, Shoki, et al.
Publicado: (2023)

Effects of sedative-hypnotics on sleep quality among patients with insomnia: evidence from an observational, pre-post study in India
por: Satheesh, Gautam, et al.
Publicado: (2020)

Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
por: Mogavero, Maria P, et al.
Publicado: (2023)

An approach to long-term sedative-hypnotic use
por: Shahid, Azmeh, et al.
Publicado: (2012)

The neuropharmacology of the age-old sedative/hypnotic, ethanol
por: Stevenson, Glenn W., et al.
Publicado: (2013)

Scopolamine as a Hypnotic and Sedative in Mental Diseases
Publicado: (1906)

Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist
por: Krause, Andreas, et al.
Publicado: (2022)

Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013)

Association between Sedative-hypnotics and Subsequent Cancer in Patients with and without Insomnia: A 14-year Follow-up Study in Taiwan
por: Fang, Hui-Fen, et al.
Publicado: (2019)

Marine Polyphenol Phlorotannins as a Natural Sleep Aid for Treatment of Insomnia: A Review of Sedative–Hypnotic Effects and Mechanism of Action
por: Kim, Seonghui, et al.
Publicado: (2022)

Atomistic Model for Simulations of the Sedative Hypnotic Drug 2,2,2-Trichloroethanol
por: Kiametis, Alessandra S., et al.
Publicado: (2018)

Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies
por: Ming, Yingzi, et al.
Publicado: (2019)

Discontinuation of hypnotics during cognitive behavioural therapy for insomnia
por: Zavesicka, Lucie, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_995hbj4hs4vskjjdudls810tr2